Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 383

Results For "Mark"

5366 News Found

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Healthcare | September 23, 2022

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune


JB Pharma witness 20% growth in August 2022: IQVIA
News | September 22, 2022

JB Pharma witness 20% growth in August 2022: IQVIA

Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.


Aster Pharmacy forays into Bangladesh
Healthcare | September 22, 2022

Aster Pharmacy forays into Bangladesh

Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.


Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners
Opinion | September 22, 2022

Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners

Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.


Shilpa Medicare receives tentative approval for Tenofovir Alafenamide Tablets
Drug Approval | September 22, 2022

Shilpa Medicare receives tentative approval for Tenofovir Alafenamide Tablets

The ANDA was filed as 'First to File' submission on NCE-1 date.


Tezspire approved in the EU for the treatment of severe asthma
Drug Approval | September 21, 2022

Tezspire approved in the EU for the treatment of severe asthma

First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations


Azelis expands pharmaceutical offerings with Clariant
News | September 21, 2022

Azelis expands pharmaceutical offerings with Clariant

Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.


DAMAN enters ambitious European precision medicine healthcare project
News | September 21, 2022

DAMAN enters ambitious European precision medicine healthcare project

Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.


NATCO gets CTPR launch approval from Delhi High Court
News | September 21, 2022

NATCO gets CTPR launch approval from Delhi High Court

NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole


Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
Drug Approval | September 21, 2022

Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19

Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial